Curriculum vitae
Emmanuele Venanzi Rullo M.D. PhD
evenanzirullo@gmail.com evenanzirullo@unime.it evenanzirullo@polime.it
PEC: emmanuele.venanzirullo.bxsr@rc.omceo.it
https://it.linkedin.com/in/emmanuele-venanzi-rullo-88930343
Whatsapp +39 3496495453 CF VNNMNL84S03H224V N° Ord. Med. RC8665 Cod. ENPAM 300331976Y000
Sex Male (He/Him) | Date of birth 11/03/1984 | Nationality Italian

WORK EXPERIENCE
December 2024 – Associate Professor (tenure track) of Infectious Diseases
University of Messina, Messina, Italy
December 2021 – December 2024 Senior Researcher in Infectious Diseases (RTD-B)
University of Messina, Messina, Italy
2020 - Teacher of Infectious Diseases
CdS Infermieristica, University of Messina, Messina, Italy
2020 - Teacher of Infectious Diseases
CdS Medicine and Surgery, University of Messina, Messina, Italy
2020 - Teacher of Infectious Diseases
CdS Medicina e Chirurgia, University of Messina, Messina, Italy
2020 - Teacher of Infectious Diseases
CdS Terapia della neuro e psicomotricità dell’età evolutiva, University of Messina, Messina, Italy
2020 - Teacher of Infectious Diseases
Scuola di Specializzazione in Microbiologia, University of Messina, Messina, Italy
2019 - Teacher of Infectious Diseases
Scuola di Specializzazione in Malattie Infettive, University of Messina, Messina, Italy
April 2020 - Infectious Diseases specialist physician
Ward of Infectious Diseases, University Hospital of Messina, Messina, Italy
December 2019 – December 2021 Junior Researcher in Infectious Diseases (RTD-A)
University of Messina, Messina, Italy
October 2019 - April 2020 Fellow researcher
University of Pennsylvania, Philadelphia, PA
Visiting PhD student working on HIV reservoir and latency Business or sector Medical research in Infectious diseases
May 2018 - September 2019 Visiting PhD student
University of Pennsylvania, Philadelphia, PA
2017 - 2023 Tutor and Teacher in a II level Master
University of Messina, Messina, Italy
Master: Hospital Infection control
October 2016 – September 2019 PhD student in Medical and Surgical Biotechnologies
Department of Infection Diseases of University Hospital “G. Martino” of Messina
January 2016 – June 2016 Visiting Fellow/ Resident Doctor, Consultant (Fungal Infections in immunocompromised patients)
Institute Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain
May 2015 – December 2015 Visiting Fellow/ Resident Doctor, Tropical Medicine, Madrid
Unidad de referencia nacional para Enfermedades Tropicales, Madrid, Spain
January 2015 – May 2015 Visiting Fellow/ Resident Doctor, Consultant (Bacterial and virus infections in immunocompromised patients), Madrid
Servicio de Enfermedades Infecciosas dell’Hospital Universitario “Ramón y Cajal”, Madrid, Spain
June 2011 – December 2014 Resident/fellow in Infectious Diseases
Unit of Infectious Diseases of University Hospital “G. Martino” of Messina
November 2010 – January 2011 Training Doctor
“Bianchi-Melacrinò-Morelli” Hospital, Reggio Calabria, Italy
May 2015 – June 2016 Volunteer Doctor, NGO Saludentreculturas e Dianova, Madrid, Spain
▪ Volunteer Doctor at the NGO Saludentreculturas, trainer task for health agencies and cultural mediators on health issues and infectious diseases silent and/or transmissible (Chagas disesas, HIV, hepatitis, STD, tuberculosis, etc...)
December 2010 and March 2015 Volunteer Doctor, Centre de Santé “C.S.B II ECAR Petites servantes du S. Coer”, Ambatondrazaka, Madagascar
▪ Clinical activity as a volunteer doctor at the dispensary of Ambatondrazaka, Madagascar.

EDUCATION AND TRAINING

November 2019 - November 2029 Italian National Scientific Qualification (ASN)
Qualified to tenure Associate Professor in Infectious Diseases, Italy
October 2016 - September 2019 PhD in Biotechnology Medical and Surgical
University of Messina, Messina, Italy
PhD student working on HIV reservoir and latency Business or sector Medical research in Infectious diseases
June 2011 – June 2016 Diploma of Specialization in Infectious Diseases
University of Palermo, Faculty of Medicine and Surgery, School of Specialization in Infectious Diseases
December 2014 Diploma of habilitation in medical practice - Homologación al titulo español de Licenciado en Medicina y Cirugía
Ministerio de educación, cultura y deporte, Subdirección general de titulos y reconocimiento de cualificaciones.
November 2010- February 2011 Diploma of habilitation in medical practice
University of Messina, Faculty of Medicine and Surgery
October 2003 – October 2010 Degree in Medicine and Surgery
University of Messina, Faculty of Medicine and Surgery

PERSONAL SKILLS

Mother tongue(s) Italian Other language(s)
Spanish C2 C2 C2 C1 C1
English B2 B2 B2 B2 B2
France A2 A2 A2 A2 A2

Communication skills

▪ I have good communication skills gained through my experience as a volunteer in different NGO that working with migrant population for the training of cultural mediators and health agent

Digital skills SELF-ASSESSMENT

Information processing
Communication
Content creation
Safety
Problem solving
Independent user Independent user Independent user Independent user Independent user
Levels: Basic user - Independent user - Proficient user Digital competences - Self-assessment grid

ADDITIONAL INFORMATION
Publications
1. Marino, A. et al. SARS-CoV-2 associated unilateral parotitis in children: A case report and literature review. Biomedical Reports 20, 83 (2024).
2. 2. Calabrese, V. et al. Differences in Efficacy between Antibacterial Lock Therapy and the Standard of Care for CVC-Related Infections: A Systematic Review and Meta-Analysis. Clinics and Practice 14, 1538–1549 (2024).
3. de Vito, A. et al. Assessing ChatGPT’s theoretical knowledge and prescriptive accuracy in bacterial infections: a comparative study with infectious diseases residents and specialists. Infection (2024) doi:10.1007/s15010-024-02350-6.
4. Spampinato, S. et al. Implications and considerations of V179D mutation in a patient with HIV treated with cabotegravir/rilpivirine: A case report and mini review of the literature. World Academy of Sciences Journal 6, 19 (2024).
5. Paternò Raddusa, M. S. et al. Atherosclerosis and Cardiovascular Complications in People Living with HIV: A Focused Review. Infectious Disease Reports 16, 846–863 (2024).
6. Colpani, A. et al. Viro-Immunological Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide among Women Living with HIV: A 96-Week Post-Switch Analysis from the Real-Life SHiNe-SHiC Cohort. Biomedicines 12, 2311 (2024).
7. Spampinato, S. et al. Coronavirus OC43 and Influenza H3N2 Concomitant Unilateral Parotitis: The Importance of Laboratory Tests in Mumps-Like Parotitis. Pathogens 12, 1309 (2023).
8. Bergna, A. et al. Genomic epidemiology of the main SARS‐CoV‐2 variants in Italy between summer 2020 and winter 2021. Journal of Medical Virology 95, (2023).
9. Ceccarelli, M. et al. High prevalence of pyogenic spondylodiscitis cases in a third level university infectious diseases center: A case series and literature review. World Academy of Sciences Journal 5, 27 (2023).
10. Russotto, Y. et al. COVID 19 infection and severe autoimmune haemolytic anaemia: A case report and review of the literature. World Academy of Sciences Journal 5, 31 (2023).
11. Calabrese, V. et al. Arteriovenous fistula thrombosis in hemodialysis patients with COVID-19: epiphenomenon or marker of severe clinical disease? Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia 39, (2022).
12. Facciolà, A. et al. COVID-19 and pregnancy: clinical outcomes and scientific evidence about vaccination. European review for medical and pharmacological sciences 26, 2610–2626 (2022).
13. Russotto, Y. et al. Delirium during COVID 19: A report of eight cases and a review of the literature. World Academy of Sciences Journal 5, 1 (2022).
14. Russotto, Y. et al. Diagnosis, Treatment, and Prevention of HIV Infection among Detainees: A Review of the Literature. Healthcare 10, 2380 (2022).
15. Campana, S. et al. Cutting Edge: Hyperinflammatory Monocytes Expressing CD56 Abound in Severe COVID-19 Patients. The Journal of Immunology 209, 655–659 (2022).
16. Facciolà, A. et al. Efficacy of COVID-19 Vaccination in People Living with HIV: A Public Health Fundamental Tool for the Protection of Patients and the Correct Management of Infection. Infectious Disease Reports 14, 784–793 (2022).
17. Russotto, Y., Micali, C., Pellicanò, G. F., Nunnari, G. & Venanzi Rullo, E. HIV and Mediterranean Zoonoses: A Review of the Literature. Infectious Disease Reports 14, 694–709 (2022).
18. Micali, C. et al. Loco-Regional Treatments for Hepatocellular Carcinoma in People Living with HIV. Infectious Disease Reports 14, 43–55 (2022).
19. Tosto, F. et al. Methicillin sensitive Staphylococcus aureus prosthetic vascular graft infection after a Fontan procedure in an adult patient: A case report. World Academy of Sciences Journal 4, 19 (2022).
20. Ceccarelli, M. et al. Post infectious ST elevation myocardial infarction following a COVID 19 infection: A case report. Biomedical Reports 16, 10 (2022).
21. Lai, A. et al. Phylogeography and genomic epidemiology of SARS-CoV-2 in Italy and Europe with newly characterized Italian genomes between February-June 2020. Scientific Reports 12, 5736 (2022).
22. Micali, C. et al. Thyroid Diseases and Thyroid Asymptomatic Dysfunction in People Living With HIV. Infectious Disease Reports 14, 655–667 (2022).
23. Micali, C. et al. Pulmonary Kaposi Sarcoma without Respiratory Symptoms and Skin Lesions in an HIV-Naïve Patient: A Case Report and Literature Review. Infectious Disease Reports 14, 228–242 (2022).
24. Falcone, M. et al. Superinfections caused by carbapenem-resistant Enterobacterales in hospitalized patients with COVID-19: a multicentre observational study from Italy (CREVID Study). JAC-Antimicrobial Resistance 4, (2022).
25. Ceccarelli, M. et al. New generation biologics for the treatment of psoriasis and psoriatic arthritis. State of the art and considerations about the risk of infection. Dermatologic Therapy 34, (2021).
26. Pampaloni, A. et al. “Diagnosis on the Dock” project: A proactive screening program for diagnosing pulmonary tuberculosis in disembarking refugees and new SEI model. International Journal of Infectious Diseases 106, 98–104 (2021).
27. Marino, A. et al. Entecavir resistance in a patient with treatment naïve HBV: A case report. Molecular and Clinical Oncology 14, 113 (2021).
28. Lai, A. et al. Circulating SARS-CoV-2 variants in Italy, October 2020–March 2021. Virology Journal 18, 168 (2021).
29. Bonaccorsi, I. et al. HLA-C*17 in COVID-19 patients: Hints for associations with severe clinical outcome and cardiovascular risk. Immunology Letters 234, 44–46 (2021).
30. Longhitano, E. et al. Hypernatraemia and low eGFR at hospitalization in COVID-19 patients: a deadly combination. Clinical Kidney Journal 14, 2227–2233 (2021).
31. Pirisi, M. et al. Liver infection and COVID-19: the electron microscopy proof and revision of the literature. European review for medical and pharmacological sciences 25, 2146–2151 (2021).
32. Cutroneo, P. et al. Psoriasis and psoriasiform reactions secondary to immune checkpoint inhibitors. Dermatologic Therapy 34, (2021).
33. Pavone, P. et al. SARS-CoV-2 related paediatric acute-onset neuropsychiatric syndrome. The Lancet Child & Adolescent Health 5, e19–e21 (2021).
34. Fanni, D. et al. Trace elements and the carotid plaque: the GOOD (Mg, Zn, Se), the UGLY (Fe, Cu), and the BAD (P, Ca)? European review for medical and pharmacological sciences 25, 3772–3790 (2021).
35. Catanzariti, F. et al. High-risk lesions of the breast: concurrent diagnostic tools and management recommendations. Insights into Imaging 12, 63 (2021).
36. Gulizia, C. et al. Atypical Presentation of Herpes Simplex Virus 1 Encephalitis in Pediatric Age. Open Access Macedonian Journal of Medical Sciences 9, 204–208 (2021).
37. Ceccarelli, M., Pavone, P., Venanzi Rullo, E. & Nunnari, G. Comment on safety and efficacy of oral lopinavir/ritonavir in pediatric patients with coronavirus disease: a nationwide comparative analysis. European review for medical and pharmacological sciences 25, 2473–2474 (2021).
38. Venanzi Rullo, E. et al. Non-Melanoma Skin Cancer in People Living With HIV: From Epidemiology to Clinical Management. Frontiers in Oncology 11, (2021).
39. Guarneri, C. et al. Silent COVID-19: what your skin can reveal. The Lancet Infectious Diseases 21, 24–25 (2021).
40. Ceccarelli, M., Berretta, M., Venanzi Rullo, E., Nunnari, G. & Cacopardo, B. Differences and similarities between Severe Acute Respiratory Syndrome (SARS)-CoronaVirus (CoV) and SARS-CoV-2. Would a rose by another name smell as sweet? European review for medical and pharmacological sciences 24, 2781–2783 (2020).
41. Ceccarelli, M. et al. Editorial - Coronavirus disease 2019 and people living with HIV: clinical considerations. European review for medical and pharmacological sciences 24, 7534–7539 (2020).
42. D’Andrea F. et al. EPSTEIN BARR VIRUS RELATED CANCER IN PEOPLE LIVING WITH HIV: A REVIEW OF THE LITERATURE. World Cancer Research Journal 7, e1512 (2020).
43. D’Andrea, F. et al. HEPATITIS B VIRUS INFECTION AND HEPATOCELLULAR CARCINOMA IN PLWH: EPIDEMIOLOGY, PATHOGENESIS AND TREATMENT. World Cancer Research Journal 7, e1537 (2020).
44. Facciolà, A. et al. Malignant melanoma in HIV: Epidemiology, pathogenesis, and management. Dermatologic Therapy 33, (2020).
45. Ceccarelli, M. et al. Non-AIDS defining cancers: a comprehensive update on diagnosis and management. European review for medical and pharmacological sciences 24, 3849–3875 (2020).
46. Meduri, A. et al. Ocular surface manifestation of COVID-19 and tear film analysis. Scientific Reports 10, 20178 (2020).
47. Vella, F. et al. Transmission mode associated with coronavirus disease 2019: a review. European review for medical and pharmacological sciences 24, 7889–7904 (2020).
48. Guarneri, C. et al. Diversity of clinical appearance of cutaneous manifestations in the course of COVID‐19. Journal of the European Academy of Dermatology and Venereology 34, e449–e450 (2020).
49. Venanzi Rullo, E. et al. Persistence of an intact HIV reservoir in phenotypically naive T cells. JCI Insight 5, (2020).
50. Lai, A. et al. Molecular Tracing of SARS-CoV-2 in Italy in the First Three Months of the Epidemic. Viruses 12, 798 (2020).
51. Venanzi, E. et al. Aerosolized Lipid Amphotericin B for Complementary Therapy and/or Secondary Prophylaxis in Patients with Invasive Pulmonary Aspergillosis: A Single-Center Experience. Mycopathologia 184, 239–250 (2019).
52. D’Andrea, F. et al. CERVICAL CANCER IN WOMEN LIVING WITH HIV: A REVIEW OF THE LITERATURE. World Cancer Research Journal 6, e1224 (2019).
53. D’Aleo, E. et al. ANAL CANCER IN PEOPLE LIVING WITH HIV: THE IMPORTANCE OF THE SCREENING AND OF EARLY DIAGNOSIS. World Cancer Research Journal 6, e1319 (2019).
54. D’Andrea, F. et al. Breast cancer in women living with HIV. European review for medical and pharmacological sciences 23, 1158–1164 (2019).
55. Pinzone, M. R. et al. Circulating angiopoietin-like protein 2 levels are associated with decreased renal function in HIV+ subjects on cART: A potential marker of kidney disease. Biomedical reports 10, 140–144 (2019).
56. Venanzi Rullo, E. et al. Genetic Evidence That Naive T Cells Can Contribute Significantly to the Human Immunodeficiency Virus Intact Reservoir: Time to Re-evaluate Their Role. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 69, 2236–2237 (2019).
57. Ceccarelli, M. et al. HIV‐associated psoriasis: Epidemiology, pathogenesis, and management. Dermatologic Therapy 32, e12806 (2019).
58. Venanzi Rullo, E. et al. Investigational drugs in HIV: Pros and cons of entry and fusion inhibitors (Review). Molecular Medicine Reports 19, 1987–1995 (2019).
59. Facciolà, A. et al. HODGKIN’S LYMPHOMA IN PEOPLE LIVING WITH HIV: EPIDEMIOLOGY AND CLINICAL MANAGEMENT. World Cancer Research Journal 6, e1295 (2019).
60. Cannon, L., Pinzone, M., Venanzi Rullo, E. & O’Doherty, U. Longitudinal sequencing reveals multiphasic decay of HIV reservoir. Journal of Virus Eradication 5, 30 (2019).
61. Pinzone, M. R. et al. Longitudinal HIV sequencing reveals reservoir expression leading to decay which is obscured by clonal expansion. Nature Communications 10, 728 (2019).
62. Facciolà, A. et al. The role of the hospital environment in the healthcare-associated infections: a general review of the literature. European review for medical and pharmacological sciences 23, 1266–1278 (2019).
63. Ceccarelli, M. et al. The treatment of Kaposi’s sarcoma: present and future options, a review of the literature. European review for medical and pharmacological sciences 23, 7488–7497 (2019).
64. D’Andrea, E. et al. VACCINES AGAINST HPV IN PEOPLE LIVING WITH HIV: A REVIEW. World Cancer Research Journal 6, e1348 (2019).
65. Larnè, D. et al. Bacteremic Meningitis due to Pasteurella multocida Resistant to First line Antibiotic Therapy. Infectious Disease Reports 10, 7632 (2018).
66. Ceccarelli, M. et al. Head and neck squamous cell carcinoma and its correlation with human papillomavirus in people living with HIV: a systematic review. Oncotarget 9, 17171–17180 (2018).
67. Ceccarelli, M., Condorelli, F., Venanzi Rullo, E. & Pellicanò, G. F. EDITORIAL – IMPROVING ACCESS AND ADHERENCE TO SCREENING TESTS FOR CANCERS: A NEW, THOUGH OLD, CHALLENGE IN THE HIV EPIDEMICS. World Cancer Research Journal 5, e1030 (2018).
68. D’andrea, F. et al. CANCER SCREENING IN HIV-INFECTED PATIENTS: EARLY DIAGNOSIS IN A HIGH-RISK POPULATION WCRJ 2018; 5 (3): e1130. World Cancer Research Journal 5, e1130 (2018).
69. D’Aleo, F. et al. HIV AND COLORECTAL CANCER. NEW INSIGHTS AND REVIEW OF THE LITERATURE. World Cancer Research Journal 5, e1122 (2018).
70. D’Aleo, F. et al. NEW AND OLD ASSUMPTIONS ON LUNG CANCER IN PEOPLE LIVING WITH HIV. World Cancer Research Journal 5, e1036 (2018).
71. Facciolà, A. et al. PROSTATE CANCER IN HIV-POSITIVE PATIENTS: A REVIEW OF THE LITERATURE WCRJ 2018; 5 (3): e1136. World Cancer Research Journal 5, e1136 (2018).
72. Visalli, G. et al. HPV AND URINARY BLADDER CARCINOMA: A REVIEW OF THE LITERATURE. World Cancer Research Journal 5, e1038 (2018).
73. Ceccarelli, M., Venanzi Rullo, E. & Nunnari, G. Risk factors of venous thrombo-embolism during cytomegalovirus infection in immunocompetent individuals. A systematic review. European Journal of Clinical Microbiology & Infectious Diseases 37, 381–390 (2018).
74. Ceccarelli, M. et al. Unusual Signs and Symptoms in HIV-Positive Patients Coinfected with Leishmania spp: The Importance of Neglected Tropical Disease in Differential Diagnosis. Open Access Macedonian Journal of Medical Sciences 6, 843–847 (2018).
75. Crespillo-Andújar, C. et al. Safety Profile of Benznidazole in the Treatment of Chronic Chagas Disease: Experience of a Referral Centre and Systematic Literature Review with Meta-Analysis. Drug Safety 41, 1035–1048 (2018).
76. Atteritano, M. et al. Vitamin D Status and the Relationship with Bone Fragility Fractures in HIV-Infected Patients: A Case Control Study. International Journal of Molecular Sciences 19, 119 (2018).
77. Cama, B. A. v et al. Outbreak of Brucella melitensis infection in Eastern Sicily: risk factors, clinical characteristics and complication rate. The new microbiologica 41, 1121–7138 (2018).
78. Facciolà, A. et al. Kaposi’s sarcoma in HIV-infected patients in the era of new antiretrovirals. European review for medical and pharmacological sciences 21, 5868–5869 (2017).
79. D’Aleo, F. et al. Hepatitis C-related hepatocellular carcinoma: diagnostic and therapeutic management in HIV-patients. European review for medical and pharmacological sciences 21, 5859–5867 (2017).
80. Venanzi, E. & López-Vélez, R. [Current management of imported severe malaria]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 29 Suppl 1, 66–71 (2016).
81. Fortún, J. et al. Galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive aspergillosis in non-hematological patients. Journal of Infection 72, 738–744 (2016).
82. Venanzi, E. & López-Vélez, R. [Resistance to the antimalarial drugs]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 29 Suppl 1, 72–5 (2016).

Memberships
Member SIMIT
Member SIMPIOS
Member SEIMC
Member SIMM
Member SITA